Successful treatment of linear IgA disease with salazosulphapyridine and intravenous immunoglobulins.
Goebeler
M
M
Seitz
C
C
Rose
C
C
Sitaru
C
C
Jeschke
R
R
Marx
A
A
Bröcker
E B
EB
Zillikens
D
D
D000293:Adolescent; D001327:Autoimmune Diseases / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D012872:Skin Diseases, Vesiculobullous / Q000628:therapy*; D012460:Sulfasalazine / Q000627:therapeutic use*
D005765:Gastrointestinal Agents; D007070:Immunoglobulin A; D016756:Immunoglobulins, Intravenous; D012460:Sulfasalazine